SELE and metabolic dysfunction-associated steatotic liver disease: Elevated levels of E-selectin have been detected in patients with non-alcoholic fatty liver disease (NAFLD) and alcohol-related liver disease (ARLD), making it a promising biomarker for disease monitoring and prognosis.